What We're Reading: Page 240
Industry reads hand-picked by our editors
Jun 07, 2019
-
Science
A missed Alzheimer's opportunity? Not so much
-
The New York Times
An Australian doctor's dream: Curing America's opioid curse
-
Newsweek
Gizmodo slams drug company with 'correction' for increasing anti-seizure medicine by nearly 100,000 percent
-
The Guardian
Big pharma is denying children like my son vital drugs. So I've set up a buyers club
Jun 06, 2019
-
In The Pipeline
A Missed Alzheimer’s Opportunity? Not So Much
-
STAT
A celebrated drug hunter went after Alzheimer's. Here's how he lost
-
The Boston Globe
Third Rock raises $770 million in new funding round
-
The New York Times
Trump Administration Sharply Curtails Fetal Tissue Medical Research